These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 18992912)
1. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma. Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605 [TBL] [Abstract][Full Text] [Related]
3. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832 [TBL] [Abstract][Full Text] [Related]
4. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma. Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma. Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma. Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136 [TBL] [Abstract][Full Text] [Related]
8. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma. Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528 [TBL] [Abstract][Full Text] [Related]
9. Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Chin D; Boyle GM; Williams RM; Ferguson K; Pandeya N; Pedley J; Campbell CM; Theile DR; Parsons PG; Coman WB Laryngoscope; 2005 Jul; 115(7):1239-42. PubMed ID: 15995513 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Ma S; Guan XY; Lee TK; Chan KW Hum Pathol; 2007 Aug; 38(8):1201-6. PubMed ID: 17442377 [TBL] [Abstract][Full Text] [Related]
11. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830 [TBL] [Abstract][Full Text] [Related]
13. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151 [TBL] [Abstract][Full Text] [Related]
14. Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Montorsi M; Maggioni M; Falleni M; Pellegrini C; Donadon M; Torzilli G; Santambrogio R; Spinelli A; Coggi G; Bosari S Hepatogastroenterology; 2007; 54(79):2040-4. PubMed ID: 18251156 [TBL] [Abstract][Full Text] [Related]
15. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC]. Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260 [TBL] [Abstract][Full Text] [Related]
16. Association of NET-1 gene expression with human hepatocellular carcinoma. Chen L; Wang Z; Zhan X; Li DC; Zhu YY; Zhu J Int J Surg Pathol; 2007 Oct; 15(4):346-53. PubMed ID: 17913940 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma. Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732 [TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma. Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370 [TBL] [Abstract][Full Text] [Related]
20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]